Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary sarcoidosis].

F K Rømer1, M Iversen, N Milman

  • 1Dansk Lungemedicinsk Selskab.

Ugeskrift for Laeger
|January 8, 1990
PubMed
Summary
This summary is machine-generated.

Sarcoidosis, a systemic granulomatous disease, primarily affects the lungs. Most patients do not require treatment due to high spontaneous resolution rates, reserving steroids for severe cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.

Open forum infectious diseases·2018
Same author

Donor Smoking and Older Age Increases Morbidity and Mortality After Lung Transplantation.

Transplantation proceedings·2017
Same author

Patient blood management in obstetrics: management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement.

Transfusion medicine (Oxford, England)·2017
Same author

The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.

European journal of nuclear medicine and molecular imaging·2016
Same author

Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.

PloS one·2016
Same author

Clinicians' perspective on key domains in ANCA-associated vasculitis: a Delphi exercise.

Scandinavian journal of rheumatology·2016
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Immunology
  • Pathology

Context:

  • Sarcoidosis is a systemic granulomatous disease of unknown origin.
  • Pulmonary involvement dominates the clinical presentation and prognosis in most cases.
  • Characterized by T-lymphocyte-driven interstitial inflammation and non-caseating granulomas, potentially leading to fibrosis.

Purpose:

  • To review the types and courses of pulmonary sarcoidosis.
  • To evaluate diagnostic measures for disease activity.
  • To critically assess the role of systemic corticosteroids in managing sarcoidosis.

Summary:

  • Pulmonary function tests, chest radiography, and serum angiotensin-converting enzyme (S-ACE) are key indicators of sarcoidosis activity.
  • High spontaneous resolution rates suggest observation is appropriate for many patients.

Related Experiment Videos

  • Systemic corticosteroids are recommended for symptomatic, progressive lung disease or critical extrathoracic sarcoidosis.

    • Impact:

    • Treatment decisions for sarcoidosis should be individualized based on disease severity and progression.
    • Early intervention with prednisolone may prevent disabling pulmonary fibrosis in persistent cases.
    • This review guides clinical management, emphasizing conservative approaches and targeted corticosteroid use.